Baidu
map

Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?

Ren, L; Reyes, CM; Friess, H; Demir, IE

Demir, IE (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany.; Demir, IE (corresponding author), German Canc Consortium DKTK, Partner Site Munich, Munich, Germany.; Demir, IE (corresponding author), CRC 1321 Modelling & Targeting Pancreat Canc, Munich, Germany.; Demir, IE (corresponding author), Acibadem Mehmet Ali Aydinlar Univ, Sch Med, HPB Unit, Dept Gen Surg, Istanbul, Turkey.

LANGENBECKS ARCHIVES OF SURGERY, 2020; 405 (7): 879

Abstract

Background Neoadjuvant therapies (neoTx) have revolutionized the treatment of borderline resectable (BR) and locally advanced (LA) pancreatic cancer (......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

Baidu
map
Baidu
map
Baidu
map